首页 | 本学科首页   官方微博 | 高级检索  
     

新型冠状病毒Delta变异株感染同船海员的临床特点分析
引用本文:黄华艳,林春光,陈永东,曾其毅,吴昌儒. 新型冠状病毒Delta变异株感染同船海员的临床特点分析[J]. 临床荟萃, 2022, 37(4): 311. DOI: 10.3969/j.issn.1004-583X.2022.04.004
作者姓名:黄华艳  林春光  陈永东  曾其毅  吴昌儒
作者单位:广西防城港市第一人民医院医院感染管理科,广西防城港538021;广西防城港市第一人民医院神经内科,广西防城港538021;广西防城港市第一人民医院心血管内科,广西防城港538021;广西防城港市第一人民医院呼吸内科,广西防城港538021;广西防城港市第一人民医院重症医学科,广西防城港538021
摘    要:目的 探讨新型冠状病毒Delta变异株感染同船海员的临床特点及接种疫苗的保护作用。方法 回顾分析2021年8-11月广西防城港市第一人民医院定点隔离病区收治的新型冠状病毒Delta变异株境外输入感染者5例及同船海员17例。依据是否接种疫苗分为接种疫苗组(10例)及未接种疫苗组(12例),回顾性分析两组临床资料。结果 同船22例海员中新型冠状病毒感染共14例(63.6%);其中未接种疫苗组感染比例高于接种疫苗组(P<0.05)。除外2例为无症状感染,其余12例出现发热、嗅味觉减退、咳嗽、胸闷、咳痰、乏力及全身酸痛等。未接种疫苗组发热持续时间为(7.62±2.32)天,接种疫苗组发热持续时间为(6.25±2.50)天,差异无统计学意义(P=0.368)。经治疗后未接种疫苗组核酸转阴时间为(65.75±25.81)天,而接种疫苗组为(44.00±28.32)天,差异无统计学意义(P=0.211)。结论 我国生产疫苗对新型冠状病毒Delta变异株具有一定的保护作用。同船海员新型冠状病毒Delta变异株感染患者核酸转阴时间明显延长,但接种疫苗与核酸转阴时间无相关性。

关 键 词:新型冠状病毒肺炎  COVID-19疫苗  临床特点
收稿时间:2021-12-15

Clinical characteristics of Delta variant of SARS-CoV-2 of shipmate
Huang Huayan,Lin Chunguang,Chen Yongdong,Zeng Qiyi,Wu Changru. Clinical characteristics of Delta variant of SARS-CoV-2 of shipmate[J]. Clinical Focus, 2022, 37(4): 311. DOI: 10.3969/j.issn.1004-583X.2022.04.004
Authors:Huang Huayan  Lin Chunguang  Chen Yongdong  Zeng Qiyi  Wu Changru
Affiliation:a. Department of Hospital Infection Management, Fangchenggang 538021, Chinab. Department of Neurology, Fangchenggang 538021, Chinac. Department of Cardiology, Fangchenggang 538021, Chinad. Department of Respiratory, Fangchenggang 538021, Chinae. Department of Critical Care, the First People's Hospital of Fangchenggang, Fangchenggang 538021, China
Abstract:Objective To explore the clinical characteristics of the B.1.617.2 (Delta) variant of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) of shipmates, and the protective effect of SARS-CoV-2 vaccines. Methods From August to November 2021, five imported cases of Delta variants of SARS-CoV-2 and 17 shipmates were enrolled, who all visited fixed point isolation endemic area of the First People's Hospital of Fangchenggang, and divided into the vaccinated group (n=10) and the unvaccinated group (n=12), the clinical data of the two groups were retrospectively analyzed. Results Among the 22 shipmates, there were 14 cases of SARS-CoV-2 infection, with the infection rate of 63.6%; the unvaccinated group was more common (P<0.05). Of 14 cases, 12 had clinical symptoms (fever, olfactory and taste loss, cough, chest tightness, expectoration, fatigue, and body aches) except for 2 asymptomatic SARS-CoV-2 infections. The difference was not statistically significant in fever duration between the vaccinated group and the unvaccinated group ([7.62±2.32] days vs [6.25±2.50] days, [P=0.368], respectively); the negative conversion time of SARS-CoV-2 nucleic acid in the unvaccinated group and the vaccinated group was (65.75±25.81) days and (44.00±28.32) days, respectively, and with no statistically significant difference (P=0.211). Conclusion The present data showed that domestic vaccine has a protective effect against the Delta variant of SARS-CoV-2. Both the prolonged time of negative conversion and whether or not vaccination have no correlation.
Keywords:COVID-19  COVID-19 vaccines  clinical characteristics  
本文献已被 万方数据 等数据库收录!
点击此处可从《临床荟萃》浏览原始摘要信息
点击此处可从《临床荟萃》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号